Ketamine One, OVR Tech Partner for Olfactory VR Treatments

"Ketamine One Capital announced on Wednesday it had inked an exclusive deal with OVR Tech for virtual reality (VR) olfactory treatments aimed at deepening immersion, relaxation, and lowering stress.
OVR Tech will provide its solutions to Ketamine One’s psychedelic-assisted treatments, which include ketamine, DMT, psilocybin, and MDMA to boost patient outcomes, the company said in a statement.
OVR’s INHALE Wellness Platform works with breathwork, meditation, and mindfulness treatments along with aromatherapy. The Vermont-based firm’s ION platform also includes a VR headset with scented cartridges, simulating nature scenes to deepen immersive experiences.
The ‘Scent’ platform’s Olfactory Experience Engine triggers water-based scents during VR experiences delivered via the cartridges, which have been tested extensively in studies.
Patients at Ketamine One’s clinics receive the experiences via the company’s Immersive Virtual Reality service.
According to the firm’s research, scent therapy sparks “emotional and evocative associations and can immediately alter mood”. Additional data revealed odours immediately activated parts of the brain associated with memories, emotions, and associations, boosting therapeutic efficacy.
Dr Quang Henderson, Chair of Ketamine One’s Clinic Innovation Council, said his company believe the ION system’s ability to alter perceptual experiences was “extremely promising”.
According to Adam Deffett, Interim Chief Executive of Ketamine One, the firm’s contract research organisation, KGK Science, along with greater access to a large number of patients and its OVR platform, could potentially lead clinically tested solutions for clinics as well as patient homes by developing portable digital therapeutic systems in the future..." Lire la suite